ATE280182T1 - Inaktivierter impfstoff gegen katzen calicivirus - Google Patents

Inaktivierter impfstoff gegen katzen calicivirus

Info

Publication number
ATE280182T1
ATE280182T1 AT00953242T AT00953242T ATE280182T1 AT E280182 T1 ATE280182 T1 AT E280182T1 AT 00953242 T AT00953242 T AT 00953242T AT 00953242 T AT00953242 T AT 00953242T AT E280182 T1 ATE280182 T1 AT E280182T1
Authority
AT
Austria
Prior art keywords
vaccine against
inactivated vaccine
against calicivirus
calicivirus
inactivated
Prior art date
Application number
AT00953242T
Other languages
English (en)
Inventor
Herve Poulet
Sylvain Gabriel Goutebroze
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9909420A external-priority patent/FR2796281B1/fr
Application filed by Merial Sas filed Critical Merial Sas
Application granted granted Critical
Publication of ATE280182T1 publication Critical patent/ATE280182T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/106—Picornaviridae (F), e.g. hepatitis A virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16061—Methods of inactivation or attenuation
    • C12N2770/16063—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00953242T 1999-07-16 2000-07-13 Inaktivierter impfstoff gegen katzen calicivirus ATE280182T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9909420A FR2796281B1 (fr) 1999-07-16 1999-07-16 Vaccin inactive contre la calicivirose feline
FR0001759A FR2796282B1 (fr) 1999-07-16 2000-02-11 Vaccin inactive contre la calicivirose feline
PCT/FR2000/002050 WO2001005835A1 (fr) 1999-07-16 2000-07-13 Vaccin inactive contre la calicivirose feline

Publications (1)

Publication Number Publication Date
ATE280182T1 true ATE280182T1 (de) 2004-11-15

Family

ID=26212168

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00953242T ATE280182T1 (de) 1999-07-16 2000-07-13 Inaktivierter impfstoff gegen katzen calicivirus

Country Status (17)

Country Link
EP (1) EP1194450B1 (de)
JP (1) JP4841775B2 (de)
KR (3) KR100934687B1 (de)
AR (1) AR024770A1 (de)
AT (1) ATE280182T1 (de)
AU (1) AU6576400A (de)
BR (1) BR0012500B1 (de)
CA (1) CA2378802C (de)
DE (1) DE60015127T2 (de)
DK (1) DK1194450T3 (de)
ES (1) ES2231233T3 (de)
FR (1) FR2796282B1 (de)
HU (1) HU228430B1 (de)
MX (1) MXPA02000536A (de)
PL (1) PL205298B1 (de)
PT (1) PT1194450E (de)
WO (1) WO2001005835A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7850978B2 (en) * 1999-07-16 2010-12-14 Merial Limited Vaccine against feline calicivirus
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
PL1734992T3 (pl) * 2004-01-21 2012-02-29 Merial Inc Ulepszone inaktywowane szczepionki fcv
CN103550767B (zh) * 2005-07-28 2017-04-19 硕腾服务有限责任公司 疫苗施用方法、新猫杯状病毒、及抗猫细小病毒和猫疱疹病毒的动物免疫方法
KR102796617B1 (ko) * 2022-07-14 2025-04-24 대한민국 고양이 바이러스 감염 질병의 예방 또는 경감용 조성물 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE119545T1 (de) * 1989-07-21 1995-03-15 Upjohn Co Felincalicivirus-capsid-protein und nukleotidsequenz.
JP3514482B2 (ja) * 1992-02-28 2004-03-31 財団法人化学及血清療法研究所 抗ネコカリシウイルス組換え抗体および該抗体からなる治療剤
US6231863B1 (en) * 1997-06-10 2001-05-15 American Cyanamid Company DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same

Also Published As

Publication number Publication date
EP1194450B1 (de) 2004-10-20
PT1194450E (pt) 2005-03-31
DK1194450T3 (da) 2005-02-21
FR2796282A1 (fr) 2001-01-19
DE60015127T2 (de) 2005-10-13
BR0012500B1 (pt) 2011-03-22
MXPA02000536A (es) 2002-07-30
AU6576400A (en) 2001-02-05
DE60015127D1 (de) 2004-11-25
JP4841775B2 (ja) 2011-12-21
HUP0202389A3 (en) 2003-12-29
KR100859824B1 (ko) 2008-09-23
HUP0202389A2 (hu) 2002-12-28
PL205298B1 (pl) 2010-04-30
CA2378802A1 (en) 2001-01-25
HU228430B1 (en) 2013-03-28
FR2796282B1 (fr) 2001-10-26
AR024770A1 (es) 2002-10-23
KR20080012405A (ko) 2008-02-11
KR100934687B1 (ko) 2009-12-31
PL352461A1 (en) 2003-08-25
CA2378802C (en) 2012-01-24
KR20090007803A (ko) 2009-01-20
EP1194450A1 (de) 2002-04-10
JP2003505400A (ja) 2003-02-12
KR20020020785A (ko) 2002-03-15
ES2231233T3 (es) 2005-05-16
WO2001005835A1 (fr) 2001-01-25
BR0012500A (pt) 2002-04-02

Similar Documents

Publication Publication Date Title
ATE312624T1 (de) Impfstoff gegen hpv
NO20014322D0 (no) Vaksine
NO20031483L (no) Vaksine
CY2011008I2 (el) Εμβολιο γριπης
NO20021433L (no) Vaksiner
NO20024172L (no) Vaksine
DE69923434D1 (de) Adjuvierte rekombinante Lebendimpfstoffe gegen Influenza- oder Herpesviren
PL363005A1 (pl) Szczepionki
EP1458242A4 (de) Polyvalente konjugatvakzine gegen krebs
EP1307130A4 (de) Impfstoff gegen menschlichen immunschwächevirus
DK1427444T3 (da) West-nil-vaccine
NO20020763D0 (no) Vaksine
DK1265633T3 (da) Vaccineadjuvans
NO20033882L (no) Vaksine
EP1423141A4 (de) Vakzine
NO20052149D0 (no) Vaksine.
DE60226218D1 (de) Impfstoff gegen pferdeherpesvirus
ATE280182T1 (de) Inaktivierter impfstoff gegen katzen calicivirus
DE60125927D1 (de) Impfstoffe gegen hiv
EP1105154A4 (de) Impfstoffe gegen bakterielle superantigene
IS2797B (is) Bóluefni gegn ISA-veiru
ATE333894T1 (de) Vakzine gegen infektiöse bursitis
ATE346870T1 (de) Natürlicher antikörper mit wirkung gegen das hiv virus
ATA6762000A (de) Zahnärztliches oder chirurgisches winkelstück
NO20033463D0 (no) Kranvinkeldose

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties